U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 011771

Expand all

ATHROMBIN-K (WARFARIN POTASSIUM)
2MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN POTASSIUM
Proprietary Name: ATHROMBIN-K
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 007
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ATHROMBIN-K (WARFARIN POTASSIUM)
5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN POTASSIUM
Proprietary Name: ATHROMBIN-K
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ATHROMBIN-K (WARFARIN POTASSIUM)
10MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN POTASSIUM
Proprietary Name: ATHROMBIN-K
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ATHROMBIN-K (WARFARIN POTASSIUM)
25MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN POTASSIUM
Proprietary Name: ATHROMBIN-K
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ATHROMBIN (WARFARIN SODIUM)
5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: ATHROMBIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ATHROMBIN (WARFARIN SODIUM)
10MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: ATHROMBIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ATHROMBIN (WARFARIN SODIUM)
25MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: ATHROMBIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N011771
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACEUTICAL RESEARCH ASSOC INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top